IPO Premiums
IPO calendar
MHMETROPOLISListed

Metropolis Healthcare Limited

Bookbuilding IPO · NSE, BSE

Price band
₹877 - ₹880
Lot size
17 shares
Issue amount
₹1,204 cr
Total subscription
0×
Current price₹519.1
Listing price ₹958
Watch live price ↗
Opens
3 Apr 2019
Closes
5 Apr 2019
Allotment
10 Apr 2019
Listing
15 Apr 2019

Offer at a glance

Issue overview

Issue size
1,36,85,095 shares
Face value
₹2 per share
Minimum investment
₹14,909
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Ltd
Listing exchange
NSE, BSE
Maximum investment
₹14,960
Issue type
Bookbuilding IPO
Shares before issue
5,01,78,680
Shares after issue
5,01,78,680

Lot sizes

CategoryLotsSharesAmount
RETAIL117₹14,960
sHNI14238₹2,09,440
bHNI671,139₹10,02,320

Share reservation

QIB73.36%
HNI14.67%
RETAIL9.78%
Employee2.19%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
02,0004,0006,0008,000Mar-16 · Revenue: 4,754.69Mar-16 · Profit after tax: 819.55Mar-16Mar-17 · Revenue: 5,447.24Mar-17 · Profit after tax: 1,072.57Mar-17Mar-18 · Revenue: 6,435.67Mar-18 · Profit after tax: 1,097.47Mar-18Dec-18 · Revenue: 5,593.06Dec-18 · Profit after tax: 887.71Dec-18
RevenueProfit after tax

Company information

Company profile

Incorporated in 1980, Mumbai-based Metropolis Healthcare Limited is a chain of diagnostic companies operating 106 clinical laboratories and 1,130 collection centers across seven countries, with a presence in 18 states and 173 cities in India for disease monitoring, early detection, and diagnostic screening. The company offers 3,480 clinical laboratory tests and 524 profiles, combining various tests for specific diseases, and serves around 7.7 million patients annually, conducting approximately 16 million tests. It also provides analytical and support services for clinical research projects and follows a 'hub and spoke' model to enhance service delivery. Internationally, Metropolis has laboratory operations in Ghana, Zambia, Kenya, Sri Lanka, and Mauritius, and offers third-party services in UAE, Nepal, Nigeria, and Oman. The company has been recognized for excellence in customer service and delivery by Biotrains, for service excellence by FICCI, and as "best in health and fitness" by LH Insights in 2018.

Strengths

  • Industry-Ready: Well-positioned to benefit from expected industry growth.
  • Widespread Operations: Extensive operational network across regions.
  • Comprehensive Test Menu: Offers a broad range of testing services.
  • Quality & Service Focus: Emphasizes high-quality standards and customer satisfaction.
  • Strong IT Infrastructure: Robust technology systems supporting operations.

Promoters

Dr Sushil Kanubhai Shah

Ameera Sushil Shah

Metz Advisory LLP

Registrar & documents

Lead manager

Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, Hdfc Bank Limited, Jm Financial Limited, Kotak Mahindra Capital Company

Registered office

250 D Udyog Bhavan, Hind Cycle Marg, Worli Mumbai 400 030, Maharashtra

(91 22) 6258 2810

[email protected]Company website ↗

Understanding METROPOLIS IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.